Unknown

Dataset Information

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.


ABSTRACT:

Purpose

A melanoma vaccine incorporating six peptides designed to induce helper T-cell responses to melanoma antigens has induced Th1-dominant CD4(+) T-cell responses in most patients, and induced durable clinical responses or stable disease in 24% of evaluable patients. The present study tested whether this vaccine also induced antibody (Ab) responses to each peptide, and whether Ab responses were associated with T-cell responses and with clinical outcome.

Experimental design

Serum samples were studied from 35 patients with stage III-IV melanomas vaccinated with 6 melanoma helper peptides (6MHP). IgG Ab responses were measured by ELISA. Associations with immune response and overall survival were assessed by log-rank test and χ(2) analysis of Kaplan-Meier data.

Results

SUBMITTER: Reed CM 

PROVIDER: S-EPMC4558239 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature